Protagenic Therapeutics secures $250,000 loan from Patness

• Protagenic Therapeutics issued a $250,000 promissory note to Patness on November 4, 2026.
• Repayment falls due 180 days from issuance or upon closing an equity capital raise of at least $1 million, whichever occurs first.
• The note carries 1% annual simple interest, forgiven if all obligations are paid in full before 365 days from issuance.
• The borrower may prepay the note in whole or in part without premium or penalty.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagenic Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-050420), on November 06, 2026, and is solely responsible for the information contained therein.